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Robotic surgery is considered as one of the advanced treatment modality of minimally invasive 
surgery for rectal cancer. Robotic rectal surgery has been performed for three decades and its 
application is gradually expanding along with technology development. It has several technical 
advantages which include magnified three-dimensional vision, better ergonomics, multiple articulated 
robotic instruments, and the opportunity to perform remote surgery. The technical benefits of robotic 
system can help to manipulate more meticulously during technical challenging procedures including 
total mesorectal excision in narrow pelvis, lateral pelvic node dissection, and intersphincteric 
resection. It is also reported that robotic rectal surgery have been shown more favorable postoperative 
functional outcomes. Despite its technical benefits, a majority of studies have been reported that there 
is rarely clinical or oncologic superiority of robotic surgery for rectal cancer compared to 
conventional laparoscopic surgery. In addition, robotic rectal surgery showed significantly higher 
costs than the standard method. Hence, the cost-effectiveness of robotic rectal surgery is still 
questionable. In order for robotic rectal surgery to further develop in the field of minimally invasive 
surgery, there should be an obvious cost-effective advantages over laparoscopic surgery, and it is 
crucial that large-scale prospective randomized trials are required. Positive competition of industries 
in correlation with technological development may gradually reduce the price of the robotic system, 
and it will be helpful to increase the cost-effectiveness of robotic rectal surgery.
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INTRODUCTION
Minimally invasive surgery has remarkably developed dur-
ing the past decades, but, it is still challenging and needs a lot 
of technical demands. In the early 1990s, laparoscopic surgery 
appeared and has grown rapidly, then has been established as 
a standard method of minimally invasive surgery.1 According 
to several randomized studies, comparing open surgery, lapa-
roscopic surgery has clinical benefits including smaller inci-
sions, shorter hospital stay, and better postoperative recovery 
with comparable oncologic outcomes.2-4 Meanwhile, the robot-
ic system provides magnified three-dimensional vision, better 
ergonomics, multiple articulated robotic instruments, and an 
opportunity to perform remote surgery.5 In terms of the ad-
vantage to approach narrow pelvic cavity, robotic surgery has 
been used prominently in the urologic and gynecologic fields. 
In recent, robotic rectal surgery including a robot-assisted 
laparoscopic approach or totally robotic surgery is increasing 
and regarded as an effective and surgeon-convenient treat-
ment option that is suggested to overcome the limitations of 
laparoscopic surgery.6 Even though robotic surgery has those 
technical advantages, the cost-effectiveness of robot-assisted 
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rectal surgery is still debatable. We herein reviewed the over-
view of robotic rectal surgery, and discussed in terms of cost-
effectiveness based on the literatures.
DEVELOPMENT OF ROBOTIC SURGERY
The surgical use of a robot in a machine has approximately 
30 years of history.7 The first clinical use of a robot for sur-
gery was the Automated Endoscopic System for Optimal 
Positioning (AESOP; Computer Motion Inc. Santa Barbara, 
CA), developed by Wang, in 1993. In the next year, AESOP 
was approved by the Food and Drug Administration (FDA) 
as an endoscopic camera manipulator. A few years later, the 
Zeus system (Computer Motion, Inc., Santa Barbara, CA) was 
invented with surgical arms and instruments, but it had a 
limited role as an assistant. After then, the da Vinci® system 
(Intuitive Surgical, Inc., Mountain View, CA) has been used in 
general surgery. Zeus system was decided to stop production in 
2003, hence, the da Vinci® system is the only available surgical 
robot.8,9 Since Jacques Himpens and Gut Cardiere performed 
the first robot-assisted cholecystectomy in 1997, various gen-
eral surgical procedures were performed with the da Vinci® 
system.7,10 In the early 2000s, Hashizume and Weber reported 
the first robotic colectomy for malignant and benign disease 
respectively.7,11,12 The first radical mesorectal excision of rectal 
cancer using the da Vinci® system was reported by Pigazzi et 
al.13 in 2006. Up to now, the da Vinci® system is developed Xi 
version with reduced docking time and improved image qual-
ity, and additionally, SP version for surgical access of narrow 
space.
PROS AND CONS OF ROBOTIC RECTAL 
SURGERY
Robotic rectal surgery has several benefits compared with 
conventional laparoscopic surgery. It offers magnified three-
dimensional view, hand-tremor filtering, fine dexterity with 
wrist articulation, surgeon comfort in console, and, assistant-
independent operation of working arms and camera.5,14,15 The 
high resolution of the robotic visual system is helpful to pre-
serve the pelvic autonomic nerve.16 Furthermore, better ergo-
nomics and surgeon comfort design including sitting available 
at a console during surgery, and meticulous EndowristTM (In-
tuitive Surgical, Sunnyvale, CA, USA) movement might reduce 
the fatigue of operator compared to conventional laparoscopic 
surgery.17 Especially, robotic total mesorectal excision (TME) 
has a potential benefit because of its technical difficulty to 
access the narrow pelvic cavity.13 Beak et al.16 reported that 
there was no significant difference among the easy, moderate, 
and difficult pelvic anatomy groups stratified by MRI-based 
pelvimetry, in terms of operation time and other perioperative 
outcomes for robotic TME. It implied that robotic approach 
can be comfortable to access narrow cavity, and it is more 
helpful to overcome difficulties regarding pelvic anatomy. 
In addition, several studies suggested that better recovery 
of urinary and sexual function in the robotic rectal surgery 
group comparing the laparoscopic rectal surgery group for the 
reason of more precise and meticulous dissection in robotic 
TME.18-20 For the same reason, robotic system is regarded as 
a useful option when technically demanding procedures are 
required such as intersphincteric resection, or lateral pelvic 
lymph nodes.21-23
On the other hand, there is controversy regarding high 
cost, patient repositioning difficulty, complete loss of tactile 
feedback, and prolonged operative time.1,15,24,25 The docking 
procedure of the robotic cart is required more time and addi-
tional efforts. Furthermore, it is difficult to remove the robotic 
cart promptly, when an emergent open conversion is neces-
sary, such as uncontrolled bleeding. Tactile feedback is useful 
during surgery, which provides numerous sensations when 
surgeons manipulate surgical procedures such as traction, pal-
pation, grasping, pulling, and push of the structure, moreover, 
notification of tissue damage. Although technical develop-
ment may improve the haptic feedback of the robotic surgical 
system, it does not yet provide the fine haptic feedback to the 
surgeon as accurately as the human touch sensation.26,27 The 
high cost is the main drawback of robotic surgery. The cost 
analysis is described at the bottom of the body text.
LEARNING CURVE 
Although laparoscopic rectal surgery has been an alterna-
tive treatment of open surgery, in terms of surgeon’s training, 
it requires a steeper learning curve than open surgery, because 
of its non-ergonomic surgical instruments and limited surgi-
cal view.28,29 The robotic surgical system provides better er-
gonomic tools, and high-resolution three-dimensional vision, 
therefore, it is expected that the learning curve is shorter than 
the laparoscopic procedure.
The learning curve of robotic rectal surgery was reported 
rage from 15 to 40 cases,30-35 whereas the value of laparoscopic 
rectal surgery was reported 30 to 70 cases.28,36,37 The learning 
curve of robotic surgery may be seen shorter than laparoscop-
ic surgery, however, most studies have a single-arm design, 
and they have consisted of a small number of patients.
Park et al.38 analyzed a single junior surgeon’s learning curve 
of robotic TME for rectal cancer with 89 cases and compared 
them with the same size of conventional laparoscopic surger-
ies using the cumulative sum (CUSUM) method. In this study, 
the single surgeon started laparoscopic and robotic TME al-
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most simultaneously. The learning curve of robotic surgery 
for rectal cancer was 44 procedures and laparoscopic surgery 
was 41 procedures. According to the study, the learning curves 
between the two methods showed similar results with compa-
rable clinicopathologic outcomes.
However, a majority of published studies did not consider 
the surgeon’s prior experience of rectal surgery, which could 
affect the learning curve as a bias. Furthermore, the case 
complexity could be one of the influencing factors. Darcy et 
al. suggested that robotic rectal surgery may accelerate the 
learning curve when operating more complex cases compared 
with laparoscopic surgery because the perioperative outcomes 
were improved while case complexity increased.39 Therefore, 
the superiority of the learning curve between laparoscopy 
and robotic rectal surgery is controversial, and further studies 
should consider influencing factors that may cause bias.
PERIOPERATIVE OUTCOMES
It is established that robotic rectal surgery is safe and fea-
sible compared to conventional minimally invasive surgery. 
Although the results in detail might vary depending on the 
studies, the recent comparative studies between laparoscopic 
and robotic TME for rectal cancer showed overall comparable 
clinical outcomes (Table 1).40-48 In 2008, Baik et al.40 reported 
a pilot randomized controlled study for comparing robotic and 
laparoscopic tumor-specific mesorectal excision (TSME) with 
a small population, the results showed that the mean operative 
time was not significantly different between the two groups 
(217.1±51.6 vs. 204.3±51.9, p=0.477). According to Park et 
al.42 and Polat et al.48, the operative time also reported no dif-
ference. However, except for those studies, the other studies 
have shown that robotic rectal surgery not only showed longer 
operative time,43-47 but also shorter operative time41 than lapa-
roscopic rectal surgery. Ramji et al.44 suggested that the learn-
ing curve and the familiarity of docking systems are the major 
factors of difference in operative time. 
In terms of estimated blood loss (EBL) during operation, 
most of the studies reported that there was no significant dif-
ference between robotic and laparoscopic rectal surgery. Ac-
cording to Kim et al.46, the median EBL was higher in the ro-
botic surgery group than in the laparoscopic surgery group (100 
mL vs 50 mL, p<0.0001), but, all the patients of both groups 
did not require blood transfusions.
The length of hospital stay (LOS) of robotic TME is gener-
ally similar or slightly shorter than laparoscopic surgery.40-48 
Baik et al.40 presented the mean LOS of robotic rectal surgery 
was shorter than the laparoscopic approach (6.9±1.3 days vs 8.7
±1.3 days, p<0.001) in the short-term follow up. Park et al.42 
also reported similar results regarding LOS in long-term fol-
low up (5.86±1.43 days vs 6.54±2.65 days, p=0.035).
Regarding postoperative morbidity, robotic surgery has 
barely shown a significant difference compared to laparo-
scopic surgery. The complication rates of robotic TME were 
ranged from 14.3% to 47.6%, while those of laparoscopic TME 
were ranged from 5.5% to 49.4%.40-48 Meanwhile, according to 
Baik et al.49, overall postoperative complication rates of both 
groups had no statistical difference (10.7 vs 19.3, p=0.202), but, 
the major complication rate of robotic low anterior resection 
were significantly lower than that of laparoscopic surgery (5.4 
vs 19.3, p=0.025). This study suggested that the lower major 
complication rate in the robotic surgery group may be associ-
ated with a faster start of the diet and shorter length of hospi-
tal stay.
The range of conversion rate of robotic rectal surgery has 
been reported 0 to 12%.40-48 It is shown that the conversion 
rate of robotic TME had no statistical difference compared 
with laparoscopic TME,40,43-46 whereas, several studies sug-
gested that robotic TME had a lower conversion rate than that 
of laparoscopic TME.41,42,48 According to the ‘Robotic vs Lapa-
roscopic Resection for Rectal Cancer (ROLARR)’ randomized 
controlled trial which published the primary results at JAMA 
in 2017, there was no significant difference in conversion rates 
between robotic TME and conventional laparoscopic TME 
(8.1% vs 12.2%, p=0.16).50 High body mass index and male af-
fected open conversion rate because of its technical difficulty 
to manipulate in the limited abdomino-pelvic cavity. Fur-
thermore, the significant lower conversion rate is reported in 
patients who underwent low anterior resection comparing with 
abdominoperineal resection, it is probably because that the 
major part of the oncological component is performed through 
the trans-perineal approach, not laparoscopic approach.50
FUNCTIONAL OUTCOMES
One of the potential benefits of robotic rectal cancer surgery 
is that it can lead better perioperative functional outcomes 
regarding voiding and sexual aspects. Pelvic autonomic nerve 
injury during TME procedure is a crucial cause of voiding and 
sexual dysfunction. The International Prostate Symptom Score 
(IPSS) and the International Index of Erectile Function (IIEF) 
questionnaires are generally used to assess urogenital dys-
function. According to a systematic review and meta-analysis, 
in ten studies including 689 patients which were evaluated the 
functional outcomes by IPSS and IIEF, robotic rectal surgery 
showed early improved urogenital function compared to lapa-
roscopic rectal surgery.51 In recent, Wang et al.52 also reported 
that robotic rectal surgery showed less incidence of male uri-
nary and sexual dysfunction. The postoperative 12 months to-
tal IPSS scores were significantly lower in robotic group than 
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laparoscopic group (6.79 vs 9.66, p=0.037), and the postopera-
tive 12 months total IIEF scores were significantly higher in 
robotic group than laparoscopic group (46.2 vs 40.1, p=0.043). 
It might be because the robotic system provides a clearer field 
of view and better ergonomics, therefore, they result in more 
meticulous manipulation for pelvic dissection comparing with 
laparoscopic approach. Robotic surgery seems to be more ef-
fective than laparoscopic surgery for pelvic autonomic nerve 
preservation in TME procedure, however, large-populated 
randomized trial is required.
ONCOLOGIC OUTCOMES
The oncologic outcomes of robotic TME are generally com-
parable to those of laparoscopic TME. Table 2 shows the on-
cologic outcomes of robotic TME for rectal cancer compared 
with conventional surgery in recently published studies, and 
there are rarely statistical differences between robotic TME 
and laparoscopic TME.40-48
The completeness of oncologic resection was reflected by 
the pathologic outcomes of the specimen including the num-
ber of harvested lymph nodes (LN), circumferential resec-
tion margin (CRM), and distal resection margin (DRM). The 
harvested LN of both groups were mostly more than 12 in 
the majority of studies. According to Kim et al.46 and Asoglu 
et al.47, the number of harvested LN of the robotic group was 
statistically higher than that of the laparoscopic group (18 vs 
15, p=0.04, and 32 vs 23, p=0.008), while a lot of other stud-
ies showed no significant difference.40-42,44,45,48 In terms of 
CRM involvement and the length of DRM, the results of both 
groups were also similar. Baik et al.49 compared complete-
ness of the TME specimen between robotic and laparoscopic 
groups macroscopically, and the robotic group was superior to 
the laparoscopic group (p=0.033), hence, it might account for 
the technical advantage of the robotic system regarding more 
meticulous dissection. Nevertheless, the pathologic outcomes 
including harvested LN, CRM, and DRM showed no differ-
ences.49 
In short-term oncologic outcomes of robotic TME, the 
3-year overall survival (OS), and 3-year disease-free sur-
vival (DFS) were ranged 90.1~97.0%, and 73.7~79.2%, respec-
tively.49,53-58 Pai et al.54 reported that the local recurrence was 
4% and the systemic recurrence was 17%. Another study by 
Baek et al.53 reported that the local recurrence was 3.1% with 
the mean time of 23 months, and the systemic recurrence was 
6.3%. According to Feroci et al.59, comparing with laparo-
scopic TME, robotic TME did not show statistical difference 
regarding 3-year OS (robotic vs laparoscopic; 90.2% vs 90.0%, 
p=0.956), DFS (79.2% vs 83.4%, p=0.268), local recurrence rate 
(1.9% vs 5.2%, p=0.618), and distant metastasis rate (17% vs 
8.6%, p=0.256).
Park et al.42 reported the first article to compare the long-
term oncologic outcomes between robotic and laparoscopic 
rectal surgery during the mean follow-up of 54.4 months. The 
5-year OS (robotic vs laparoscopic; 92.8% vs 93.5%, p=0.829), 
DFS (81.9% vs 78.7%, p=0.547), and local recurrence rate (2.3% 
vs 1.2%, p=0.649) between two groups had no difference. Aso-
glu et al.47 recently reported the similar long-term comparing 
results with the mean follow-up of 92 months ( OS: 83.3% vs 
75.4%, p=0.55, DFS: 81.8% vs 74.7%, p=0.662).
Up to now, although expecting that robotic TME would 
improve the quality of the specimen through technically more 
meticulous manipulation than laparoscopic TME, previous re-
sults have not provided a clear advantage in pathologic, short-
term and long-term oncologic outcomes. However, there have 
been no results of level Ⅰ evidence, randomized controlled 
trial will be required. The long-term follow up results of the 
ROLARR trial which is the largest multicenter randomized 
study will be quite helpful to establish robotic rectal cancer 
surgery regarding oncologic surgery and selection of surgical 
approach.
COST ANALYSIS
In order to shift the paradigm of specific therapeutic mo-
dality in modern medicine, not only the clinical outcomes 
of the patients, but also the price competitiveness should be 
available. The main drawback of robotic surgery is relatively 
higher costs compared to laparoscopic surgery. In general, the 
overall total costs for one patient from hospital admission to 
discharge are consisted of operative costs (including the cost 
of the operation room in relation to the operative time, and 
laparoscopic or robotic devices, consumable instruments, etc.) 
and other hospitalization costs (including the cost associated 
with length of hospital stay; medication, nursing care, blood 
transfusion, radiologic exam, nutrition, fluid administration, 
other consumables, etc.). Table 3 demonstrates the recently 
published studies regarding cost analysis of robotic TME for 
rectal cancer comparing with the conventional approach. Al-
most all the studies suggested that robotic TME had definitely 
higher costs than laparoscopic surgery.42,44,45,60-64
In South Korea, Baek et al.60 reported that total hospi-
tal charges of robotic rectal surgery are larger than those of 
laparoscopic rectal surgery (14647 vs 9978, USD, p=0.001). 
The charge for anesthesia, laboratory, radiology, nursing care, 
and medical therapy was not different between two groups, 
but operative charges were significantly higher in the robotic 
surgery group (8849 vs 2289, USD, p≤0.001). The main cost 
portion of the robotic surgery group was operative cost (60.3%), 
whereas that of the laparoscopic surgery group was consum-
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ables (33.7%). The operative costs of robotic colorectal surgery 
are non-deductible in the South Korean health care system. 
Kim et al.61 analyzed the cost-effectiveness of robotic rectal 
cancer surgery focusing on short-term outcomes using pro-
pensity score-matching method. Comparing the laparoscopic 
group (n=251), the robotic group (n=251) showed similar short-
term clinical outcomes, but higher costs in all categories of 
charges (total hospital charges, patients’ payment, operative 
charges, anesthetic charges, and postoperative management 
charges). Park et al.42 reported a comparison of costs between 
robotic low anterior resection group and laparoscopic low an-
terior resection group with long-term oncologic outcomes. As 
mentioned above, they had similar long-term oncologic out-
comes, however, the patients’ payment of robotic surgery was 
2.34 times higher than that of laparoscopic surgery (10029.4 
vs 4285.2, USD, p<0.001), and the total cost was also higher in 
robotic surgery (12742.5 vs 10101.3, USD, p<0.001). 
In Italy, Morelli et al.62 reported a single surgeon’s initial 50 
robotic rectal resection experience focusing on cost analysis 
according to the learning curve using the CUSUM method 
comparing with laparoscopic TME. They divided the costs 
into two categories which are fixed costs (costs related to ro-
botic equipment or laparoscopic device), and variable costs 
(costs related to disposable instruments, operating room per-
sonnel, and length of stay). Based on the CUSUM method, 
the robotic TME group was divided into three phases (Rob1: 
1~19, Rob2: 20~40, Rob3: 41~50) and there was a statistical 
change in the operative time of each phase. Total costs were 
significantly higher in the robotic TME group (12283.5 vs 
7619.8, EUR, p<0.001), and variable costs were also higher in 
the robotic TME group comparing with the laparoscopic TME 
group (10614.6 vs 7585.4, EUR, p<0.001). Costs were higher for 
Rob1 comparing with Rob3 (p<0.009), and it may be reflected 
that the reduction of overall costs was caused by the reduc-
tion of operative time with an increase of robotic experience. 
Excluding fixed costs, there was no significant difference in 
variable costs between the Rob3 group and the laparoscopic 
TME group (p=0.084). According to this article, however, total 
costs were still higher in the robotic group even if the surgeon 
reaches the experienced phase of robotic TME (p<0.001). 
In Canada, Ramji et al.44 compared the clinical and eco-
nomic outcomes among three approaches of rectal cancer 
surgery (open, laparoscopic, and robotic) in a publicly funded 
healthcare system. There was no statistical difference for to-
tal costs and operative costs between open and laparoscopic 
method, whereas, robotic surgery added approximately 6000 
CAD to the median costs of each operation, increasing the av-
erage cost of stay for a patient by 1.5 times with similar clini-
cal outcomes (Operative costs: open vs laparoscopic vs robotic, 
4339.63 vs 5313.59 vs 11879.66, CAD, p<0.001). Silva-Velazco 
et al.45 from the United States also reported a comparison of 
the clinical and cost analysis of proctectomy in patients with 
rectal cancer by open, laparoscopic, and robotic surgery. The 
total median cost of all hospitalizations per patient, the ro-
botic group required significantly higher costs (p<0.001). This 
finding was also detected when comparing the robotic group 
with an open group (p<0.001) or a laparoscopic group (p<0.001) 
respectively, while there was no difference in the open group 
compared to the laparoscopic group (p=0.18). When the me-
dian total cost for open surgery was accounted for 100%, the 
median total cost for the laparoscopic group was 104%, and 
that of the robotic group was 131%.
In Spain, Ielpo et al.63 reported a comparative study of clini-
cal outcomes and costs for robotic versus laparoscopic surgery 
for rectal cancer. The mean operative costs were significantly 
higher for the robotic group (4285.16 vs 3506.11, EUR, p=0.04), 
but, the mean overall costs were similar in both groups (7279.31 
vs 6879.80, EUR, p=0.44). The mean hospitalization costs of 
the robotic group were 3383.71 EUR, and that of the laparo-
scopic group was 2994.14 EUR (p=0.63). However, since this 
study did not include fixed costs for robotic surgery (acquisition 
or maintenance of the robotic device), different results could 
be derived.
There was a largely populated retrospective analysis us-
ing the Nationwide Inpatient Sample database in the United 
States.64 After propensity score matching, the study included 
883 matched patients each in the open and laparoscopic group, 
and 551 matched patients each in the laparoscopic and robotic 
group. Although the p value was not demonstrated, the robotic 
group had a higher median total cost comparing with the lap-
aroscopic group (20628 vs 17671, USD). For further analysis, 
using odd ratio, the robotic group had a significantly higher 
cost than laparoscopic group (odds ratio 1.42, 95% confidence 
index 1.13~1.79), but no benefit over laparoscopic surgery in 
terms of mortality and morbidity.
In summary, almost all studies suggested that robotic TME 
showed higher cost comparing with laparoscopic TME while 
the overall clinical outcomes were similar. After the learning 
curve for robotic TME, the operative costs could be reduced, 
but the total costs including fixed costs were still higher be-
cause of the expensive purchasing charge for the robotic sys-
tem. Because of a majority of published studies regarding cost 
analysis for robotic TME is retrospective study, large popu-
lated prospective randomized studies on the cost-effectiveness 
of robotic surgery may be warranted. 
CONCLUSIONS
Robotic surgery for rectal cancer is not only feasible and 
safe but also has various potential benefits especially surgeon-
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centered technical advantages compared to the conventional 
laparoscopic rectal surgery. Robotic system is considered as 
one of useful options when technical demanding procedures 
including TME in narrow pelvis, lateral pelvic nerve dis-
section, or intersphincteric resection are needed. However, 
robotic rectal surgery showed significant higher costs than 
laparoscopic surgery with similar overall clinical outcomes. 
The overall costs are higher in robotic surgery than the lapa-
roscopic approach, especially it is account for manifestly 
expensive operative costs. Therefore, although robotic rectal 
surgery has several benefits, it is not enough to be a cost-
effective approach in the field of minimally invasive surgery 
in the present time. Because of the price of robotic equip-
ment is mainly high, it may lead to different results in the 
future. Positive competition of industries in correlation with 
technological development may gradually reduce the price of 
the robotic system, and it will be helpful to increase the cost-
effectiveness of robotic rectal surgery with acceptable results 
of large populated prospective randomized studies.
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